Author
Johns Hopkins UniversityORCID 0000-0001-5225-4609Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Nour Sabiha Naji, Taha S. Ahmedna, J. David Peske…·Theodoros Karantanos
This paper develops an anti-CCRL2 antibody-drug conjugate (ADC) that shows potent cytotoxicity against high-risk MDS/AML cells without harming healthy hematopoietic cells.
Qin Yang, Miguel Torres‐Martín, Masataka Taguchi…·María E. Figueroa
This study identifies epigenetic subtypes of MDS using DNA methylation patterns and develops a predictive signature for azacitidine response.
Nour Sabiha Naji, Sergiu Paşca, Theodora Chatzilygeroudi…·Theodoros Karantanos
This study identifies CCRL2 as a driver of IFN-γ signaling in TP53-mutated AML with erythroid differentiation, linking it to disease progression and poor outcomes.
Jonathan K. Alder, Vidya Sagar Hanumanthu, Margaret A. Strong…·Mary Y. Armanios
This study evaluates the diagnostic and prognostic value of telomere length measurement in a hospital setting, finding it alters treatment decisions in a subset of bone marrow failure patients.